SCHEMBL7598232

SCHEMBL7598232

CCCC(CC)C(=O)CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.52
CHRM3 P20309 2/20 0.52
ADRA1A P35348 2/20 0.52
AKR1A1 P14550 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
HRH1 P35367 1/20 0.52
DRD3 P35462 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
TSHR P16473 3/20 0.50
CYP3A4 P08684 2/20 0.50
NFKB1 P19838 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
HDAC7 Q8WUI4 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14543666 0.89 TDP1 (0.57) CHRM1CHRM3ADRA1AAKR1A1HTR2A
SCHEMBL10031685 0.85 CA2 (0.64) CA2MAPK1CA1SLC1A3SLC1A2
SCHEMBL15218406 0.83 CA2 (0.56) CA2MAPK1CA1SLC1A2SLC1A1
SCHEMBL5372259 0.83
SCHEMBL19679638 0.82 HDAC7 (0.50) CHRM1CHRM3ADRA1AAKR1A1HTR2A
SCHEMBL20838325 0.82 HDAC1 (0.50) CHRM1CHRM3ADRA1AAKR1A1HTR2A
SCHEMBL9987438 0.82 HDAC1 (0.50) CHRM1CHRM3ADRA1AAKR1A1HTR2A
SCHEMBL11467720 0.82 HDAC1 (0.50) CHRM1CHRM3ADRA1AAKR1A1HTR2A
SCHEMBL128715 0.81 CA2 (0.54) CA2MAPK1CA1GRIK1GRIK2
SCHEMBL30601096 0.80 CHRM1 (0.48) CHRM1CHRM3ADRA1AAKR1A1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10990013-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-04-27 US claimed
US-12222653-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2025-02-11 US disclosed
CN-113556944-A Mixture comprising D-psicose and taste modifying compound 西姆莱斯有限公司 2021-10-26 CN disclosed
CN-113507843-A Mixtures comprising rare sugars and taste modifying compounds 西姆莱斯有限公司 2021-10-15 CN disclosed
US-20210286269-A1 METHOD FOR FORMING SEMICONDUCTOR STRUCTURE TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2021-09-16 US disclosed
US-20210286269-A1 METHOD FOR FORMING SEMICONDUCTOR STRUCTURE TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2021-09-16 US disclosed
US-11009796-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-05-18 US disclosed
US-11009796-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-05-18 US disclosed
US-10990013-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-04-27 US disclosed
US-10990013-B2 Method for forming semiconductor structure TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2021-04-27 US disclosed
US-10838304-B2 Priming material for organometallic resist TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2020-11-17 US disclosed
CN-110828302-A Film forming method 台湾积体电路制造股份有限公司 2020-02-21 CN disclosed
US-20200050109-A1 Priming Material for Organometallic Resist TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2020-02-13 US disclosed
US-20190096675-A1 METHOD FOR FORMING SEMICONDUCTOR STRUCTURE TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2019-03-28 US disclosed
US-20190096675-A1 METHOD FOR FORMING SEMICONDUCTOR STRUCTURE TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2019-03-28 US disclosed
US-20140256666-A1 ANTIBIOTIC CONJUGATES WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ALLERGAN, INC. (US) 2014-09-11 US disclosed
EP-0492847-B2 Air curing polymer composition ROHM & HAAS (US) 2002-11-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256666-A1 ANTIBIOTIC CONJUGATES WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MMP17, NAALAD2, DNPEP CHRM1 4593/4885CHRM3 4505/4885ADRA1A 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.